H

Hangzhou AGS MedTech Co Ltd
SSE:688581

Watchlist Manager
Hangzhou AGS MedTech Co Ltd
SSE:688581
Watchlist
Price: 61.93 CNY 1.66% Market Closed
Market Cap: 5B CNY
Have any thoughts about
Hangzhou AGS MedTech Co Ltd?
Write Note

Net Margin
Hangzhou AGS MedTech Co Ltd

46.5%
Current
44%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
46.5%
=
Net Income
198.5m
/
Revenue
426.9m

Net Margin Across Competitors

Country CN
Market Cap 5B CNY
Net Margin
47%
Country US
Market Cap 206.5B USD
Net Margin
14%
Country US
Market Cap 192.8B USD
Net Margin
29%
Country US
Market Cap 148.5B USD
Net Margin
16%
Country US
Market Cap 133.8B USD
Net Margin
11%
Country IE
Market Cap 111B USD
Net Margin
13%
Country US
Market Cap 65B USD
Net Margin
9%
Country DE
Market Cap 56.7B EUR
Net Margin
8%
Country CN
Market Cap 326.2B CNY
Net Margin
33%
Country US
Market Cap 42.5B USD
Net Margin
74%
Country US
Market Cap 38.1B USD
Net Margin
9%
No Stocks Found

Hangzhou AGS MedTech Co Ltd
Glance View

Market Cap
5B CNY
Industry
Health Care

Hangzhou AGS MedTech Co., Ltd. engages in the research and development, manufacture, and sale of equipment in minimally invasive diagnosis and treat. The company is headquartered in Hangzhou, Zhejiang and currently employs 501 full-time employees. The company went IPO on 2023-05-19. The firm's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.

Intrinsic Value
86.56 CNY
Undervaluation 28%
Intrinsic Value
Price
H

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
46.5%
=
Net Income
198.5m
/
Revenue
426.9m
What is the Net Margin of Hangzhou AGS MedTech Co Ltd?

Based on Hangzhou AGS MedTech Co Ltd's most recent financial statements, the company has Net Margin of 46.5%.